KR102271528B9 - 유산균 파쇄체로 코팅된 스테비아 분말을 포함하는 비만 또는 당뇨 예방 및 치료용 조성물 - Google Patents
유산균 파쇄체로 코팅된 스테비아 분말을 포함하는 비만 또는 당뇨 예방 및 치료용 조성물Info
- Publication number
- KR102271528B9 KR102271528B9 KR1020200000844A KR20200000844A KR102271528B9 KR 102271528 B9 KR102271528 B9 KR 102271528B9 KR 1020200000844 A KR1020200000844 A KR 1020200000844A KR 20200000844 A KR20200000844 A KR 20200000844A KR 102271528 B9 KR102271528 B9 KR 102271528B9
- Authority
- KR
- South Korea
- Prior art keywords
- obesity
- diabetes
- treating
- preventing
- composition
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title 2
- 208000008589 Obesity Diseases 0.000 title 1
- 239000013592 cell lysate Substances 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 235000014655 lactic acid Nutrition 0.000 title 1
- 239000004310 lactic acid Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Child & Adolescent Psychology (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200000844A KR102271528B1 (ko) | 2020-01-03 | 2020-01-03 | 유산균 파쇄체로 코팅된 스테비아 분말을 포함하는 비만 또는 당뇨 예방 및 치료용 조성물 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200000844A KR102271528B1 (ko) | 2020-01-03 | 2020-01-03 | 유산균 파쇄체로 코팅된 스테비아 분말을 포함하는 비만 또는 당뇨 예방 및 치료용 조성물 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR102271528B1 KR102271528B1 (ko) | 2021-07-02 |
| KR102271528B9 true KR102271528B9 (ko) | 2022-12-27 |
Family
ID=76896799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020200000844A KR102271528B1 (ko) | 2020-01-03 | 2020-01-03 | 유산균 파쇄체로 코팅된 스테비아 분말을 포함하는 비만 또는 당뇨 예방 및 치료용 조성물 |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102271528B1 (ko) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010284100A (ja) * | 2009-06-11 | 2010-12-24 | B & L:Kk | ステビア発酵液の製造方法 |
| EP2789340A4 (en) * | 2011-12-07 | 2015-07-22 | Calpis Co Ltd | Fatty Substitute and / or Sugar Substitute Improver with Milk Acid Bacterium or Treatment Product Therefrom |
| KR102510154B1 (ko) | 2018-03-29 | 2023-03-16 | 한양대학교 산학협력단 | 비만유래 2형 당뇨 예방 및 치료를 위한 내장지방 대식세포 표적 비바이러스성 유전자／전달체 복합체 |
-
2020
- 2020-01-03 KR KR1020200000844A patent/KR102271528B1/ko active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR102271528B1 (ko) | 2021-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202103366B (en) | Composition for treating diabetes based on chinese medical nutrition therapy and application of composition | |
| EP4086336A4 (en) | STRAIN OF LACTOBACILLUS PLANTARUM, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC DISEASES CONTAINING SAME | |
| EP3723775A4 (en) | MICROBIAL COMPOSITIONS AND METHODS OF TREATMENT OF TYPE 2 DIABETES, OBESITY AND METABOLIC SYNDROME | |
| ZA201008807B (en) | Gip-based mixed agonists for treatment of metabolic disorders and obesity | |
| MX2011008399A (es) | Lactobacillus rhamnosus ncc4007, una mezcla probiotica y el control del peso. | |
| EP3727405A4 (en) | COMPOSITION INCLUDING LACTOBACILLUS PLANTARUM FOR THE PREVENTION AND / OR TREATMENT OF MENTAL DISORDERS | |
| MX2011008398A (es) | Lactobacillus helveticus cncm i-4095 y el control del peso. | |
| EP4086334A4 (en) | LACTOBACILLUS FERMENTUM STRAIN AND COMPOSITION THEREOF FOR PREVENTING OR TREATING METABOLIC DISEASES | |
| IL278993A (en) | Preparation and application of arginine-free substances for cancer, obesity, metabolic diseases, and related complications and diseases | |
| HK1159152A1 (en) | Coating composition, method of antifouling treatment and antifouling substrate | |
| BRPI0815649A8 (pt) | Revestimento | |
| EP4005579A4 (en) | COMPOSITION WITH LACTOBACILLUS REUTERI ATG-F4 FOR THE PREVENTION OR TREATMENT OF MUSCLE DISEASES | |
| HK1163146A1 (en) | Aqueous dispersions of polymer-enclosed particles, related coating compositions and coated substrates | |
| KR102271528B9 (ko) | 유산균 파쇄체로 코팅된 스테비아 분말을 포함하는 비만 또는 당뇨 예방 및 치료용 조성물 | |
| ZA202201337B (en) | Application of β-casein a2 and composition thereof in promoting proliferation of bifidobacterium | |
| MX2011008400A (es) | Lactobacillus rhamnosus cncm i-4096 y el control del peso. | |
| EP3911345A4 (en) | SPORE-BASED PROBIOTIC COMPOSITION FOR MODULATION OF DERMAL AND SUBDERMAL PROPERTIES | |
| IL285197A (en) | Methods and preparations for the treatment of sleep apnea | |
| EP3579834A4 (en) | TREATMENT OF DIABETES AND ASSOCIATED METABOLIC CONDITIONS WITH EPIGENETIC MODULATORS | |
| EP2660826A4 (en) | WHITE CONDUCTIVE POWDER, CONDUCTIVE MIXING POWDER, DISPERSION LIQUID, COATING MATERIAL AND MEMBRANE COMPOSITION | |
| EP3978005A4 (en) | COMPOSITION FOR THE PREVENTION, MITIGATION OR TREATMENT OF THE METABOLIC SYNDROME ACCOMPANYING OBESITY AND/OR DIABETES, WITH AS AN ACTIVE INGREDIENT A COMPLEX (IB-COMPLEX) OF AMLA TREE EXTRACT AND GERMINATED BARLEY EXTRACT | |
| EP3817535C0 (en) | THERMALLY CONDUCTIVE ELECTROMAGNETIC WAVES ABSORBING COMPOSITION AND FILM PRODUCED THEREFROM | |
| EP3778555A4 (en) | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE PREVENTION OR TREATMENT OF OBESITY OR METABOLIC SYNDROME | |
| EP3815696A4 (en) | COMPOSITION COMPRISING AN ANTISENSE OLIGONUCLEOTIDE AND ITS USE FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | |
| EP3761985A4 (en) | Compositions and methods for treatment of insulin resistance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| G170 | Re-publication after modification of scope of protection [patent] |